Drägerwerk AG & Co. KGaA
General ticker "DRWKF" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.6B (TTM average)
Drägerwerk AG & Co. KGaA follows the US Stock Market performance with the rate: 37.8%.
Estimated limits based on current volatility of 2.0%: low 100.45$, high 105.07$
Factors to consider:
- Company pays dividends (annually): last record date 2026-05-12, amount 2.66$ (Y2.65%)
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [61.28$, 95.43$]
- 2026-12-31 to 2027-12-31 estimated range: [64.88$, 100.30$]
Financial Metrics affecting the DRWKF estimates:
- Negative: with PPE of 9.1 at the end of fiscal year the price was high
- Positive: Operating cash flow per share per price, % of 18.97 > 12.90
- Positive: -5.39 < Operating profit margin, % of 6.84
- Positive: 1.81 < Return on assets ratio (scaled to [-100,100]) of 4.11
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
- Positive: 42.59 < Shareholder equity ratio, % of 49.63 <= 64.29
Short-term DRWKF quotes
Long-term DRWKF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €3,373.50MM | €3,370.88MM | €3,480.59MM |
| Operating Expenses | €3,189.38MM | €3,190.87MM | €3,242.40MM |
| Operating Income | €184.13MM | €180.01MM | €238.19MM |
| Non-Operating Income | €-42.81MM | €-4.62MM | €-22.63MM |
| Interest Expense | €31.10MM | €27.06MM | €22.87MM |
| R&D Expense | €325.36MM | €333.07MM | €319.27MM |
| Income(Loss) | €141.32MM | €175.39MM | €215.56MM |
| Taxes | €29.33MM | €50.63MM | €75.26MM |
| Net Income(Loss)* | €110.43MM | €124.41MM | €139.44MM |
| Stockholders Equity | €1,406.78MM | €1,535.15MM | €1,625.72MM |
| Inventory | €648.16MM | €654.34MM | €635.83MM |
| Assets | €3,094.55MM | €3,093.43MM | €3,275.73MM |
| Operating Cash Flow | €189.68MM | €167.31MM | €238.24MM |
| Capital expenditure | €68.21MM | €63.78MM | €71.79MM |
| Investing Cash Flow | €-67.34MM | €-43.39MM | €-98.11MM |
| Financing Cash Flow | €-154.56MM | €-161.38MM | €-83.96MM |
| Earnings Per Share** | €5.89 | €6.63 | €7.44 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.